Annual Reports

Browse

Browsing Annual Reports by Author "The Australian Nuclear Science and Technology Organisation"

Now showing 1 - 6 of 6
  • Thumbnail Image
    Item
    ANSTO annual report 2000-01
    (Australian Nuclear Science and Technology Organisation, 2001) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation. It has a staff of approximately 800 and is located at the Lucas Heights Science and Technology Centre, some 40 km south west of Sydney city centre. The science and technology centre occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO operates Australia’s only nuclear reactor, the research reactor HIFAR (which stands for High Flux Australian Reactor). The reactor is used to produce radioactive products for use in medicine and industry. It is also used extensively as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. The facility is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, an inner west suburb of Sydney. ANSTO provides the broad range of technical expertise needed to support Australia’s nuclear interests. It advises the Commonwealth Government on issues associated with the nuclear fuel cycle and the operation of nuclear facilities and it supports industry through the development and application of nuclear science based technology and associated capabilities. ANSTO organises its activities under six core business areas. Safety and environmental protection arrangements at ANSTO facilities are reported against separately. Further information about the organisation is available on ANSTO’s web site at www.ansto.gov.au.
  • Thumbnail Image
    Item
    ANSTO annual report 2004-05
    (Australian Nuclear Science and Technology Organisation, 2005) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its final stages of construction. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2005-06
    (Australian Nuclear Science and Technology Organisation, 2006) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its commissioning phase. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2006-07
    (Australian Nuclear Science and Technology Organisation, 2007) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 950 staff, ANSTO is responsible for delivering specialised advice, scientific services and products togovernment, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the Open Pool Australian Light-water reactor (OPAL), Australia’s new $470 million research reactor, particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. OPAL is Australia’s only operating nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The High Flux Australian Reactor (HIFAR), which was Australia’s first reactor, was officially shut down in January 2007 and is currently awaiting decommissioning. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The Organisation’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    Corporate social responsibility report 2003-04
    (Australian Nuclear Science and Technology Organisation, 2005) The Australian Nuclear Science and Technology Organisation
    This report reflects our desire to share and communicate with our various stakeholders; whether they support the work we do or are opposed to it. There are a number of mechanisms through which we invite people to interact with us, and we welcome continuing discussion on a range of issues relevant to our operations. As many already know, ANSTO operates at the leading edge of nuclear medicine, helping thousands of Australians enjoy healthier lives every year. Australians have benefited from our work in assisting the aerospace, agriculture, manufacturing, mining, minerals, food and oil exploration sectors. Our work in developing techniques to investigate climate change, salinity and groundwater pollution has also added greatly to the understanding and advancement of environmental research in these areas. What is important to us is our insistence to deliver these medical, industrial and scientific benefits through safe and secure operational management. Indeed, the excellent safety record of our High Flux Australian Reactor (HIFAR) has been maintained over the 47 years of its operation and we are vigilant in our compliance with the license regulations required by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) for our facilities and radioactive sources. The challenge for us is to find ways to ensure we continue to deliver these services and responsibilities openly and transparently without compromising classifications, regulations or confidentialities. We are not claiming to be perfect but we desire the opportunity to illustrate, identify and explore those aspects of our work that we do well, along with those that require further improvement. While many significant achievements occurred during 2003-04, one of the most noteworthy was our obtaining ISO 14001 certification - the world’s highest possible environmental performance standard. Nuclear science by its very nature means we must be extremely precise in our handling and production of radiopharmaceuticals and radioisotopes. With ISO 14001, we now accept the responsibility to ensure that we take the same duty of care with our day-to-day use of everything from drinking water to the quantity of paper used and the energy we consume. What will become apparent as you read this report is that ISO 14001 instils a sense of duty and ownership among every employee to find ways to work smarter, more safely and securely and in ways that leave the smallest footprint possible on the environment. The year ahead presents a new set of challenges and activities, including preparing to say goodbye to the HIFAR, which has served the organisation so well over the past half-century, and to the commissioning of OPAL, the Open Pool Australian Light-water reactor. OPAL will be a state-of-the art nuclear facility that will give us even greater capabilities in developing nuclear medicines and other products. For now, though, we invite you to join us in our first attempt at a consolidated assessment of the core values, strategies and policies across every sphere of our activities, ranging from community and workplace relations to environmental, health and safety practices. We seek to share with you our successes and identify those areas of operation that require further review and refinement. Our objective in this journey is not only to interact with staff, customers and stakeholders, but with our neighbours, who figure greatly in our continued success.
  • Thumbnail Image
    Item
    Corporate social responsibility report 2004-05
    (Australian Nuclear Science and Technology Organisation, 2005) The Australian Nuclear Science and Technology Organisation
    The essence of this report is showing how we constantly examine all aspects of our multi-faceted operation: to foster successful innovation, identify emerging problems and pursue opportunities for improvement. We learn from those who know us best – our employees, customers, suppliers, research collaborators, business partners and community groups. In addition, we participate in extensive and exhaustive external reviews of our activities. These are conducted by a number of expert regulatory organisations and environmental, quality and financial auditors, as well as in our reporting to the Australian Government. The preparation for commissioning of our new OPAL (Open Pool Australian Light-water) reactor has brought particular public and regulator attention to our work over the last year, and this is set to continue. We also engaged in extensive consultation in the development of our Strategic Directions for the coming five years. As well as setting four Strategic Directions – focusing on research excellence, issues of national importance, our expertise and facilities and our external relationships – we set a new vision, mission and core values. CSR principles are woven throughout our Strategic Directions: in what we do, where we aim to be, and how we will get there. For example, our Strategic Directions give particular emphasis to nuclear medicine. Our mission includes a new element devoted to this core aspect of our work, which benefits hundreds of thousands of patients each year. In our first Strategic Direction we identify excellence as a crucial element of success. We are using our expertise, facilities and intellectual property to help solve critical social, environmental and economic problems in areas such as climate change, water management and cancer. To maximise the reach of our work and minimise duplication, we collaborate with other leading public and private sector organisations in the quest to develop new knowledge, products and services. An example of this is collaboration we have undertaken with government and international agencies, that is key to our counter-terrorism research and services, which are part of the issues of national importance on which we focus in our second Strategic Direction. As Australia’s centre of nuclear expertise and one of this country’s premier scientific facilities, we know expectations of us are high. This report aims to show how we are meeting our stakeholders’ expectations (and where we are not yet up to the mark, what we are doing to change). This effort does not just involve everyone within the organisation – it also requires that we and our key stakeholders work together in a spirit of openness and commitment for the benefit of the entire Australian community.